Brief: Herantis Pharma's Rights Issue Fully Subscribed

Herantis Pharma Oyj

31/05/2022 06:42

May 31 (Reuters) - Herantis Pharma Plc  HRTIS.HE :
    * SAID ON MONDAY PRELIMINARY RESULTS OF HERANTIS PHARMA
PLC'S
FULLY SUBSCRIBED RIGHTS ISSUE
    * HERANTIS WILL RECEIVE GROSS PROCEEDS OF APPROXIMATELY EUR
7.25
MILLION, FROM THE OFFERING
    * APPROXIMATELY 79.9 PER CENT OF THE 4,831,426 OFFER SHARES
WERE
SUBSCRIBED FOR WITH SUBSCRIPTION RIGHTS, AND APPROXIMATELY 20.1
PER CENT WERE SUBSCRIBED FOR WITHOUT SUBSCRIPTION RIGHTS
    * THE SUBSCRIPTION PRICE IN THE OFFERING WAS EUR 1.50 PER
OFFER
SHARE IN FINLAND AND SEK 15.60 PER OFFER SHARE IN SWEDEN

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr4BY6yJ
 Further company coverage: [] 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))